Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh

Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-04, Vol.16 (4), p.e0249644-e0249644
Hauptverfasser: Mahmud, Reaz, Rahman, Md Mujibur, Rassel, Mohammad Aftab, Monayem, Farhana Binte, Sayeed, S K Jakaria Been, Islam, Md Shahidul, Islam, Mohammed Monirul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0249644
container_issue 4
container_start_page e0249644
container_title PloS one
container_volume 16
creator Mahmud, Reaz
Rahman, Md Mujibur
Rassel, Mohammad Aftab
Monayem, Farhana Binte
Sayeed, S K Jakaria Been
Islam, Md Shahidul
Islam, Mohammed Monirul
description Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incidence, association, and risk factors associated with development of the post-COVID-19 syndrome. We conducted a prospective cohort study at Dhaka Medical College Hospital between June 01, 2020 and August 10, 2020. All the enrolled patients were followed up for a month after clinical improvement, which was defined according the World Health Organization and Bangladesh guidelines as normal body temperature for successive 3 days, significant improvement in respiratory symptoms (respiratory rate 93% without assisted oxygen inhalation. Among the 400 recruited patients, 355 patients were analyzed. In total, 46% patients developed post-COVID-19 symptoms, with post-viral fatigue being the most prevalent symptom in 70% cases. The post-COVID-19 syndrome was associated with female gender (relative risk [RR]: 1.2, 95% confidence interval [CI]: 1.02-1.48, p = 0.03), those who required a prolonged time for clinical improvement (p
doi_str_mv 10.1371/journal.pone.0249644
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2510234089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A657819766</galeid><doaj_id>oai_doaj_org_article_1f03476d7c2c443e8eb2a7042aa8ebf9</doaj_id><sourcerecordid>A657819766</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-70b3be5288df93a6cffa526cf099851b6a1f91b78e0ec7b2d618f16b5e649bbc3</originalsourceid><addsrcrecordid>eNqNk8uO0zAUhiMEYobCGyCwhIRgkeJbHIcFUim3SiMVcZmt5ThO61ESB9sZ0Q3PjjvNVA2aBfLCt-__7XPskyRPEZwjkqM3V3ZwnWzmve30HGJaMErvJeeoIDhlGJL7J-Oz5JH3VxBmhDP2MDkjhBMEKTlP_ny1PqTL9eXqQ4oK4Hdd5WyrgWxtt4nTtg-2lcEocGT6ONVd8G_BAvTO-l6rYK41UHZrXQA-DNUOmA5IELQLRrodUNLF_SjSDtgavJfdppGV9tvHyYNaNl4_GftZ8vPTxx_LL-nF-vNqubhIVZ7xkOawJKXOMOdVXRDJVF3LDMcOFgXPUMkkqgtU5lxDrfISVwzxGrEy04wWZanILHl-8O0b68WYOi9whiAmFPIiEqsDUVl5JXpn2nhxYaURNwvWbYSM0ahGC1RDQnNW5QorSonmusQyhxRLGYf13uvdeNpQtrraB-5kMzGd7nRmKzb2WnBIUE5JNHg1Gjj7a9A-iNZ4pZtGdtoON_dGmMIssrPkxT_o3dGN1EbGAExX23iu2puKBctyjoqcsUjN76Biq3RrVPxntYnrE8HriSAyQf8OGzl4L1bfv_0_u76csi9P2K2WTdh62wzB2M5PQXoAVfyI3un6mGQExb5MbrMh9mUixjKJsmenD3QU3dYF-Qv2Dg0w</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2510234089</pqid></control><display><type>article</type><title>Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Mahmud, Reaz ; Rahman, Md Mujibur ; Rassel, Mohammad Aftab ; Monayem, Farhana Binte ; Sayeed, S K Jakaria Been ; Islam, Md Shahidul ; Islam, Mohammed Monirul</creator><creatorcontrib>Mahmud, Reaz ; Rahman, Md Mujibur ; Rassel, Mohammad Aftab ; Monayem, Farhana Binte ; Sayeed, S K Jakaria Been ; Islam, Md Shahidul ; Islam, Mohammed Monirul</creatorcontrib><description>Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incidence, association, and risk factors associated with development of the post-COVID-19 syndrome. We conducted a prospective cohort study at Dhaka Medical College Hospital between June 01, 2020 and August 10, 2020. All the enrolled patients were followed up for a month after clinical improvement, which was defined according the World Health Organization and Bangladesh guidelines as normal body temperature for successive 3 days, significant improvement in respiratory symptoms (respiratory rate &lt;25/breath/minute with no dyspnea), and oxygen saturation &gt;93% without assisted oxygen inhalation. Among the 400 recruited patients, 355 patients were analyzed. In total, 46% patients developed post-COVID-19 symptoms, with post-viral fatigue being the most prevalent symptom in 70% cases. The post-COVID-19 syndrome was associated with female gender (relative risk [RR]: 1.2, 95% confidence interval [CI]: 1.02-1.48, p = 0.03), those who required a prolonged time for clinical improvement (p&lt;0.001), and those showing COVID-19 positivity after 14 days (RR: 1.09, 95% CI: 1.00-1.19, p&lt;0.001) of initial positivity. Patients with severe COVID-19 at presentation developed post-COVID-19 syndrome (p = 0.02). Patients with fever (RR: 1.5, 95% CI: 1.05-2.27, p = 0.03), cough (RR: 1.36, 95% CI: 1.02-1.81, p = 0.04), respiratory distress (RR: 1.3, 95% CI: 1.4-1.56, p = 0.001), and lethargy (RR: 1.2, 95% CI: 1.06-1.35, p = 0.003) as the presenting features were associated with the development of the more susceptible to develop post COVID-19 syndrome than the others. Logistic regression analysis revealed female sex, respiratory distress, lethargy, and long duration of the disease as risk factors. Female sex, respiratory distress, lethargy, and long disease duration are critical risk factors for the development of post-COVID-19 syndrome.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0249644</identifier><identifier>PMID: 33831043</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adult ; Aged ; Asthma ; Asymptomatic ; Bacterial diseases ; Bangladesh ; Bangladesh - epidemiology ; Biology and Life Sciences ; Blood coagulation ; Chronic diseases ; Chronic fatigue syndrome ; Chronic infection ; Clotting ; Cohort analysis ; Complications ; Complications and side effects ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - epidemiology ; COVID-19 - therapy ; Demographic aspects ; Dyspnea ; Epidemics ; Etiology ; Fatigue - epidemiology ; Fatigue - etiology ; Female ; Fever ; Headache ; Health risks ; Heart diseases ; Hospitals ; Humans ; Hypothalamus ; Hypoxia ; Infections ; Male ; Medical schools ; Medicine and Health Sciences ; Mental disorders ; Middle Aged ; Migraine ; Myocardial infarction ; Myocarditis ; Oxygen saturation ; Patients ; Physiological aspects ; Pneumonia ; Polymerase chain reaction ; Prospective Studies ; Recovery ; Respiratory distress syndrome ; Risk analysis ; Risk Factors ; SARS-CoV-2 ; Sepsis ; Severe acute respiratory syndrome coronavirus 2 ; Signs and symptoms ; Syndrome ; Tertiary Care Centers ; Viral diseases ; Viral infections</subject><ispartof>PloS one, 2021-04, Vol.16 (4), p.e0249644-e0249644</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Mahmud et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Mahmud et al 2021 Mahmud et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-70b3be5288df93a6cffa526cf099851b6a1f91b78e0ec7b2d618f16b5e649bbc3</citedby><cites>FETCH-LOGICAL-c758t-70b3be5288df93a6cffa526cf099851b6a1f91b78e0ec7b2d618f16b5e649bbc3</cites><orcidid>0000-0002-9427-1746 ; 0000-0001-5970-2427 ; 0000-0002-4381-1511</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031743/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031743/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33831043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahmud, Reaz</creatorcontrib><creatorcontrib>Rahman, Md Mujibur</creatorcontrib><creatorcontrib>Rassel, Mohammad Aftab</creatorcontrib><creatorcontrib>Monayem, Farhana Binte</creatorcontrib><creatorcontrib>Sayeed, S K Jakaria Been</creatorcontrib><creatorcontrib>Islam, Md Shahidul</creatorcontrib><creatorcontrib>Islam, Mohammed Monirul</creatorcontrib><title>Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incidence, association, and risk factors associated with development of the post-COVID-19 syndrome. We conducted a prospective cohort study at Dhaka Medical College Hospital between June 01, 2020 and August 10, 2020. All the enrolled patients were followed up for a month after clinical improvement, which was defined according the World Health Organization and Bangladesh guidelines as normal body temperature for successive 3 days, significant improvement in respiratory symptoms (respiratory rate &lt;25/breath/minute with no dyspnea), and oxygen saturation &gt;93% without assisted oxygen inhalation. Among the 400 recruited patients, 355 patients were analyzed. In total, 46% patients developed post-COVID-19 symptoms, with post-viral fatigue being the most prevalent symptom in 70% cases. The post-COVID-19 syndrome was associated with female gender (relative risk [RR]: 1.2, 95% confidence interval [CI]: 1.02-1.48, p = 0.03), those who required a prolonged time for clinical improvement (p&lt;0.001), and those showing COVID-19 positivity after 14 days (RR: 1.09, 95% CI: 1.00-1.19, p&lt;0.001) of initial positivity. Patients with severe COVID-19 at presentation developed post-COVID-19 syndrome (p = 0.02). Patients with fever (RR: 1.5, 95% CI: 1.05-2.27, p = 0.03), cough (RR: 1.36, 95% CI: 1.02-1.81, p = 0.04), respiratory distress (RR: 1.3, 95% CI: 1.4-1.56, p = 0.001), and lethargy (RR: 1.2, 95% CI: 1.06-1.35, p = 0.003) as the presenting features were associated with the development of the more susceptible to develop post COVID-19 syndrome than the others. Logistic regression analysis revealed female sex, respiratory distress, lethargy, and long duration of the disease as risk factors. Female sex, respiratory distress, lethargy, and long disease duration are critical risk factors for the development of post-COVID-19 syndrome.</description><subject>Adult</subject><subject>Aged</subject><subject>Asthma</subject><subject>Asymptomatic</subject><subject>Bacterial diseases</subject><subject>Bangladesh</subject><subject>Bangladesh - epidemiology</subject><subject>Biology and Life Sciences</subject><subject>Blood coagulation</subject><subject>Chronic diseases</subject><subject>Chronic fatigue syndrome</subject><subject>Chronic infection</subject><subject>Clotting</subject><subject>Cohort analysis</subject><subject>Complications</subject><subject>Complications and side effects</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - epidemiology</subject><subject>COVID-19 - therapy</subject><subject>Demographic aspects</subject><subject>Dyspnea</subject><subject>Epidemics</subject><subject>Etiology</subject><subject>Fatigue - epidemiology</subject><subject>Fatigue - etiology</subject><subject>Female</subject><subject>Fever</subject><subject>Headache</subject><subject>Health risks</subject><subject>Heart diseases</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypothalamus</subject><subject>Hypoxia</subject><subject>Infections</subject><subject>Male</subject><subject>Medical schools</subject><subject>Medicine and Health Sciences</subject><subject>Mental disorders</subject><subject>Middle Aged</subject><subject>Migraine</subject><subject>Myocardial infarction</subject><subject>Myocarditis</subject><subject>Oxygen saturation</subject><subject>Patients</subject><subject>Physiological aspects</subject><subject>Pneumonia</subject><subject>Polymerase chain reaction</subject><subject>Prospective Studies</subject><subject>Recovery</subject><subject>Respiratory distress syndrome</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>SARS-CoV-2</subject><subject>Sepsis</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signs and symptoms</subject><subject>Syndrome</subject><subject>Tertiary Care Centers</subject><subject>Viral diseases</subject><subject>Viral infections</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk8uO0zAUhiMEYobCGyCwhIRgkeJbHIcFUim3SiMVcZmt5ThO61ESB9sZ0Q3PjjvNVA2aBfLCt-__7XPskyRPEZwjkqM3V3ZwnWzmve30HGJaMErvJeeoIDhlGJL7J-Oz5JH3VxBmhDP2MDkjhBMEKTlP_ny1PqTL9eXqQ4oK4Hdd5WyrgWxtt4nTtg-2lcEocGT6ONVd8G_BAvTO-l6rYK41UHZrXQA-DNUOmA5IELQLRrodUNLF_SjSDtgavJfdppGV9tvHyYNaNl4_GftZ8vPTxx_LL-nF-vNqubhIVZ7xkOawJKXOMOdVXRDJVF3LDMcOFgXPUMkkqgtU5lxDrfISVwzxGrEy04wWZanILHl-8O0b68WYOi9whiAmFPIiEqsDUVl5JXpn2nhxYaURNwvWbYSM0ahGC1RDQnNW5QorSonmusQyhxRLGYf13uvdeNpQtrraB-5kMzGd7nRmKzb2WnBIUE5JNHg1Gjj7a9A-iNZ4pZtGdtoON_dGmMIssrPkxT_o3dGN1EbGAExX23iu2puKBctyjoqcsUjN76Biq3RrVPxntYnrE8HriSAyQf8OGzl4L1bfv_0_u76csi9P2K2WTdh62wzB2M5PQXoAVfyI3un6mGQExb5MbrMh9mUixjKJsmenD3QU3dYF-Qv2Dg0w</recordid><startdate>20210408</startdate><enddate>20210408</enddate><creator>Mahmud, Reaz</creator><creator>Rahman, Md Mujibur</creator><creator>Rassel, Mohammad Aftab</creator><creator>Monayem, Farhana Binte</creator><creator>Sayeed, S K Jakaria Been</creator><creator>Islam, Md Shahidul</creator><creator>Islam, Mohammed Monirul</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9427-1746</orcidid><orcidid>https://orcid.org/0000-0001-5970-2427</orcidid><orcidid>https://orcid.org/0000-0002-4381-1511</orcidid></search><sort><creationdate>20210408</creationdate><title>Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh</title><author>Mahmud, Reaz ; Rahman, Md Mujibur ; Rassel, Mohammad Aftab ; Monayem, Farhana Binte ; Sayeed, S K Jakaria Been ; Islam, Md Shahidul ; Islam, Mohammed Monirul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-70b3be5288df93a6cffa526cf099851b6a1f91b78e0ec7b2d618f16b5e649bbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Asthma</topic><topic>Asymptomatic</topic><topic>Bacterial diseases</topic><topic>Bangladesh</topic><topic>Bangladesh - epidemiology</topic><topic>Biology and Life Sciences</topic><topic>Blood coagulation</topic><topic>Chronic diseases</topic><topic>Chronic fatigue syndrome</topic><topic>Chronic infection</topic><topic>Clotting</topic><topic>Cohort analysis</topic><topic>Complications</topic><topic>Complications and side effects</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - epidemiology</topic><topic>COVID-19 - therapy</topic><topic>Demographic aspects</topic><topic>Dyspnea</topic><topic>Epidemics</topic><topic>Etiology</topic><topic>Fatigue - epidemiology</topic><topic>Fatigue - etiology</topic><topic>Female</topic><topic>Fever</topic><topic>Headache</topic><topic>Health risks</topic><topic>Heart diseases</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypothalamus</topic><topic>Hypoxia</topic><topic>Infections</topic><topic>Male</topic><topic>Medical schools</topic><topic>Medicine and Health Sciences</topic><topic>Mental disorders</topic><topic>Middle Aged</topic><topic>Migraine</topic><topic>Myocardial infarction</topic><topic>Myocarditis</topic><topic>Oxygen saturation</topic><topic>Patients</topic><topic>Physiological aspects</topic><topic>Pneumonia</topic><topic>Polymerase chain reaction</topic><topic>Prospective Studies</topic><topic>Recovery</topic><topic>Respiratory distress syndrome</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>SARS-CoV-2</topic><topic>Sepsis</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signs and symptoms</topic><topic>Syndrome</topic><topic>Tertiary Care Centers</topic><topic>Viral diseases</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahmud, Reaz</creatorcontrib><creatorcontrib>Rahman, Md Mujibur</creatorcontrib><creatorcontrib>Rassel, Mohammad Aftab</creatorcontrib><creatorcontrib>Monayem, Farhana Binte</creatorcontrib><creatorcontrib>Sayeed, S K Jakaria Been</creatorcontrib><creatorcontrib>Islam, Md Shahidul</creatorcontrib><creatorcontrib>Islam, Mohammed Monirul</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahmud, Reaz</au><au>Rahman, Md Mujibur</au><au>Rassel, Mohammad Aftab</au><au>Monayem, Farhana Binte</au><au>Sayeed, S K Jakaria Been</au><au>Islam, Md Shahidul</au><au>Islam, Mohammed Monirul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-04-08</date><risdate>2021</risdate><volume>16</volume><issue>4</issue><spage>e0249644</spage><epage>e0249644</epage><pages>e0249644-e0249644</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incidence, association, and risk factors associated with development of the post-COVID-19 syndrome. We conducted a prospective cohort study at Dhaka Medical College Hospital between June 01, 2020 and August 10, 2020. All the enrolled patients were followed up for a month after clinical improvement, which was defined according the World Health Organization and Bangladesh guidelines as normal body temperature for successive 3 days, significant improvement in respiratory symptoms (respiratory rate &lt;25/breath/minute with no dyspnea), and oxygen saturation &gt;93% without assisted oxygen inhalation. Among the 400 recruited patients, 355 patients were analyzed. In total, 46% patients developed post-COVID-19 symptoms, with post-viral fatigue being the most prevalent symptom in 70% cases. The post-COVID-19 syndrome was associated with female gender (relative risk [RR]: 1.2, 95% confidence interval [CI]: 1.02-1.48, p = 0.03), those who required a prolonged time for clinical improvement (p&lt;0.001), and those showing COVID-19 positivity after 14 days (RR: 1.09, 95% CI: 1.00-1.19, p&lt;0.001) of initial positivity. Patients with severe COVID-19 at presentation developed post-COVID-19 syndrome (p = 0.02). Patients with fever (RR: 1.5, 95% CI: 1.05-2.27, p = 0.03), cough (RR: 1.36, 95% CI: 1.02-1.81, p = 0.04), respiratory distress (RR: 1.3, 95% CI: 1.4-1.56, p = 0.001), and lethargy (RR: 1.2, 95% CI: 1.06-1.35, p = 0.003) as the presenting features were associated with the development of the more susceptible to develop post COVID-19 syndrome than the others. Logistic regression analysis revealed female sex, respiratory distress, lethargy, and long duration of the disease as risk factors. Female sex, respiratory distress, lethargy, and long disease duration are critical risk factors for the development of post-COVID-19 syndrome.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33831043</pmid><doi>10.1371/journal.pone.0249644</doi><tpages>e0249644</tpages><orcidid>https://orcid.org/0000-0002-9427-1746</orcidid><orcidid>https://orcid.org/0000-0001-5970-2427</orcidid><orcidid>https://orcid.org/0000-0002-4381-1511</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-04, Vol.16 (4), p.e0249644-e0249644
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2510234089
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Adult
Aged
Asthma
Asymptomatic
Bacterial diseases
Bangladesh
Bangladesh - epidemiology
Biology and Life Sciences
Blood coagulation
Chronic diseases
Chronic fatigue syndrome
Chronic infection
Clotting
Cohort analysis
Complications
Complications and side effects
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 - epidemiology
COVID-19 - therapy
Demographic aspects
Dyspnea
Epidemics
Etiology
Fatigue - epidemiology
Fatigue - etiology
Female
Fever
Headache
Health risks
Heart diseases
Hospitals
Humans
Hypothalamus
Hypoxia
Infections
Male
Medical schools
Medicine and Health Sciences
Mental disorders
Middle Aged
Migraine
Myocardial infarction
Myocarditis
Oxygen saturation
Patients
Physiological aspects
Pneumonia
Polymerase chain reaction
Prospective Studies
Recovery
Respiratory distress syndrome
Risk analysis
Risk Factors
SARS-CoV-2
Sepsis
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Syndrome
Tertiary Care Centers
Viral diseases
Viral infections
title Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A06%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Post-COVID-19%20syndrome%20among%20symptomatic%20COVID-19%20patients:%20A%20prospective%20cohort%20study%20in%20a%20tertiary%20care%20center%20of%20Bangladesh&rft.jtitle=PloS%20one&rft.au=Mahmud,%20Reaz&rft.date=2021-04-08&rft.volume=16&rft.issue=4&rft.spage=e0249644&rft.epage=e0249644&rft.pages=e0249644-e0249644&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0249644&rft_dat=%3Cgale_plos_%3EA657819766%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2510234089&rft_id=info:pmid/33831043&rft_galeid=A657819766&rft_doaj_id=oai_doaj_org_article_1f03476d7c2c443e8eb2a7042aa8ebf9&rfr_iscdi=true